Status:
NOT_YET_RECRUITING
Vaginal Dilator Therapy After Pelvic Radiation
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Pelvic Radiotherapy
Vaginal Stenosis
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study is testing a new program to help women who have had pelvic radiation therapy to use vaginal dilators more regularly. Vaginal dilators are important tools that can help prevent or treat vagi...
Detailed Description
This study is testing a new behavioral program to help women who have had pelvic radiation therapy use vaginal dilators more regularly. Vaginal dilators are important tools that help prevent or treat ...
Eligibility Criteria
Inclusion
- female sex
- adults aged 18 years or older
- diagnosed with cancer of the anus, anal canal, anorectum, cervix, uterus, vagina, vulva, and/or bladder
- completed pelvic radiation therapy in the past year
- dilator therapy recommended by medical provider and standardized dilator received from provider
- able to speak/read English
Exclusion
- aged less than 17 years
- under the care of a pelvic floor physical therapist at the time of study enrollment
- have a major/serious psychiatric concern (e.g., schizophrenia) as indicated by medical chart/medical provider
- inability to provide consent
Key Trial Info
Start Date :
August 1 2027
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2030
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT07216456
Start Date
August 1 2027
End Date
April 30 2030
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710